nodes	percent_of_prediction	percent_of_DWPC	metapath
Histamine Phosphate—CYP2C9—Sorafenib—thyroid cancer	0.0382	0.229	CbGbCtD
Histamine Phosphate—CYP3A4—Vandetanib—thyroid cancer	0.0369	0.221	CbGbCtD
Histamine Phosphate—CYP2D6—Sorafenib—thyroid cancer	0.035	0.209	CbGbCtD
Histamine Phosphate—CYP3A4—Sorafenib—thyroid cancer	0.0222	0.133	CbGbCtD
Histamine Phosphate—CYP2D6—Doxorubicin—thyroid cancer	0.0212	0.127	CbGbCtD
Histamine Phosphate—CYP3A4—Doxorubicin—thyroid cancer	0.0135	0.0808	CbGbCtD
Histamine Phosphate—Risedronate—PTGS2—thyroid cancer	0.00982	1	CrCbGaD
Histamine Phosphate—HRH3—head—thyroid cancer	0.00486	0.0867	CbGeAlD
Histamine Phosphate—HNMT—thyroid gland—thyroid cancer	0.00433	0.077	CbGeAlD
Histamine Phosphate—CA4—neck—thyroid cancer	0.00386	0.0687	CbGeAlD
Histamine Phosphate—HNMT—head—thyroid cancer	0.00384	0.0684	CbGeAlD
Histamine Phosphate—SLC22A3—saliva-secreting gland—thyroid cancer	0.00337	0.0601	CbGeAlD
Histamine Phosphate—CA4—saliva-secreting gland—thyroid cancer	0.00301	0.0536	CbGeAlD
Histamine Phosphate—HRH2—head—thyroid cancer	0.00297	0.0529	CbGeAlD
Histamine Phosphate—HNMT—lymph node—thyroid cancer	0.00269	0.0479	CbGeAlD
Histamine Phosphate—Body temperature increased—Vandetanib—thyroid cancer	0.00266	0.00371	CcSEcCtD
Histamine Phosphate—Abdominal pain—Vandetanib—thyroid cancer	0.00266	0.00371	CcSEcCtD
Histamine Phosphate—Anaemia—Sorafenib—thyroid cancer	0.00257	0.00359	CcSEcCtD
Histamine Phosphate—Oliguria—Epirubicin—thyroid cancer	0.00255	0.00356	CcSEcCtD
Histamine Phosphate—Leukopenia—Sorafenib—thyroid cancer	0.00249	0.00348	CcSEcCtD
Histamine Phosphate—Dysarthria—Epirubicin—thyroid cancer	0.00248	0.00347	CcSEcCtD
Histamine Phosphate—Creatinine increased—Epirubicin—thyroid cancer	0.00247	0.00345	CcSEcCtD
Histamine Phosphate—SLC22A5—saliva-secreting gland—thyroid cancer	0.00245	0.0437	CbGeAlD
Histamine Phosphate—Cough—Sorafenib—thyroid cancer	0.00243	0.00339	CcSEcCtD
Histamine Phosphate—Atrioventricular block—Epirubicin—thyroid cancer	0.00242	0.00338	CcSEcCtD
Histamine Phosphate—Asthenia—Vandetanib—thyroid cancer	0.00241	0.00337	CcSEcCtD
Histamine Phosphate—Hypertension—Sorafenib—thyroid cancer	0.0024	0.00335	CcSEcCtD
Histamine Phosphate—Pruritus—Vandetanib—thyroid cancer	0.00238	0.00332	CcSEcCtD
Histamine Phosphate—Arthralgia—Sorafenib—thyroid cancer	0.00237	0.00331	CcSEcCtD
Histamine Phosphate—Myalgia—Sorafenib—thyroid cancer	0.00237	0.00331	CcSEcCtD
Histamine Phosphate—Oliguria—Doxorubicin—thyroid cancer	0.00236	0.0033	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00235	0.00328	CcSEcCtD
Histamine Phosphate—Injection site reaction—Epirubicin—thyroid cancer	0.00234	0.00326	CcSEcCtD
Histamine Phosphate—CA4—trachea—thyroid cancer	0.00232	0.0413	CbGeAlD
Histamine Phosphate—Dry mouth—Sorafenib—thyroid cancer	0.00231	0.00323	CcSEcCtD
Histamine Phosphate—Diarrhoea—Vandetanib—thyroid cancer	0.0023	0.00321	CcSEcCtD
Histamine Phosphate—Dysarthria—Doxorubicin—thyroid cancer	0.0023	0.00321	CcSEcCtD
Histamine Phosphate—Creatinine increased—Doxorubicin—thyroid cancer	0.00228	0.00319	CcSEcCtD
Histamine Phosphate—Influenza like illness—Epirubicin—thyroid cancer	0.00228	0.00319	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Sorafenib—thyroid cancer	0.00227	0.00317	CcSEcCtD
Histamine Phosphate—Infection—Sorafenib—thyroid cancer	0.00225	0.00315	CcSEcCtD
Histamine Phosphate—Atrioventricular block—Doxorubicin—thyroid cancer	0.00224	0.00313	CcSEcCtD
Histamine Phosphate—Shock—Sorafenib—thyroid cancer	0.00223	0.00312	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Sorafenib—thyroid cancer	0.00222	0.00311	CcSEcCtD
Histamine Phosphate—Dizziness—Vandetanib—thyroid cancer	0.00222	0.00311	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Sorafenib—thyroid cancer	0.00222	0.0031	CcSEcCtD
Histamine Phosphate—Blood urea increased—Epirubicin—thyroid cancer	0.00222	0.0031	CcSEcCtD
Histamine Phosphate—Skin disorder—Sorafenib—thyroid cancer	0.0022	0.00308	CcSEcCtD
Histamine Phosphate—Anorexia—Sorafenib—thyroid cancer	0.00216	0.00302	CcSEcCtD
Histamine Phosphate—Injection site reaction—Doxorubicin—thyroid cancer	0.00216	0.00302	CcSEcCtD
Histamine Phosphate—Vomiting—Vandetanib—thyroid cancer	0.00214	0.00299	CcSEcCtD
Histamine Phosphate—Neoplasm—Epirubicin—thyroid cancer	0.00212	0.00297	CcSEcCtD
Histamine Phosphate—Rash—Vandetanib—thyroid cancer	0.00212	0.00296	CcSEcCtD
Histamine Phosphate—Dermatitis—Vandetanib—thyroid cancer	0.00212	0.00296	CcSEcCtD
Histamine Phosphate—Influenza like illness—Doxorubicin—thyroid cancer	0.00211	0.00295	CcSEcCtD
Histamine Phosphate—Headache—Vandetanib—thyroid cancer	0.00211	0.00294	CcSEcCtD
Histamine Phosphate—HRH2—lymph node—thyroid cancer	0.00208	0.037	CbGeAlD
Histamine Phosphate—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00207	0.00289	CcSEcCtD
Histamine Phosphate—SLC22A3—thyroid gland—thyroid cancer	0.00206	0.0367	CbGeAlD
Histamine Phosphate—Blood urea increased—Doxorubicin—thyroid cancer	0.00205	0.00287	CcSEcCtD
Histamine Phosphate—Dyspnoea—Sorafenib—thyroid cancer	0.00202	0.00283	CcSEcCtD
Histamine Phosphate—Nausea—Vandetanib—thyroid cancer	0.002	0.00279	CcSEcCtD
Histamine Phosphate—Dyspepsia—Sorafenib—thyroid cancer	0.002	0.00279	CcSEcCtD
Histamine Phosphate—Decreased appetite—Sorafenib—thyroid cancer	0.00197	0.00276	CcSEcCtD
Histamine Phosphate—Neoplasm—Doxorubicin—thyroid cancer	0.00197	0.00275	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00196	0.00274	CcSEcCtD
Histamine Phosphate—Fatigue—Sorafenib—thyroid cancer	0.00196	0.00273	CcSEcCtD
Histamine Phosphate—Constipation—Sorafenib—thyroid cancer	0.00194	0.00271	CcSEcCtD
Histamine Phosphate—Pain—Sorafenib—thyroid cancer	0.00194	0.00271	CcSEcCtD
Histamine Phosphate—SLC22A1—head—thyroid cancer	0.00191	0.034	CbGeAlD
Histamine Phosphate—SLC22A5—trachea—thyroid cancer	0.00189	0.0337	CbGeAlD
Histamine Phosphate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00186	0.00259	CcSEcCtD
Histamine Phosphate—Renal failure acute—Epirubicin—thyroid cancer	0.00185	0.00258	CcSEcCtD
Histamine Phosphate—CA4—thyroid gland—thyroid cancer	0.00184	0.0327	CbGeAlD
Histamine Phosphate—SLC22A3—head—thyroid cancer	0.00183	0.0325	CbGeAlD
Histamine Phosphate—Hot flush—Epirubicin—thyroid cancer	0.00182	0.00255	CcSEcCtD
Histamine Phosphate—Menopausal symptoms—Epirubicin—thyroid cancer	0.00181	0.00253	CcSEcCtD
Histamine Phosphate—Urticaria—Sorafenib—thyroid cancer	0.0018	0.00252	CcSEcCtD
Histamine Phosphate—Abdominal pain—Sorafenib—thyroid cancer	0.00179	0.00251	CcSEcCtD
Histamine Phosphate—Body temperature increased—Sorafenib—thyroid cancer	0.00179	0.00251	CcSEcCtD
Histamine Phosphate—Renal impairment—Epirubicin—thyroid cancer	0.00179	0.0025	CcSEcCtD
Histamine Phosphate—Renal failure acute—Doxorubicin—thyroid cancer	0.00171	0.00239	CcSEcCtD
Histamine Phosphate—Pain in extremity—Epirubicin—thyroid cancer	0.00171	0.00238	CcSEcCtD
Histamine Phosphate—Hot flush—Doxorubicin—thyroid cancer	0.00169	0.00236	CcSEcCtD
Histamine Phosphate—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00167	0.00234	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Sorafenib—thyroid cancer	0.00167	0.00234	CcSEcCtD
Histamine Phosphate—Renal impairment—Doxorubicin—thyroid cancer	0.00166	0.00232	CcSEcCtD
Histamine Phosphate—CA4—head—thyroid cancer	0.00163	0.029	CbGeAlD
Histamine Phosphate—Asthenia—Sorafenib—thyroid cancer	0.00163	0.00227	CcSEcCtD
Histamine Phosphate—Cardiac arrest—Epirubicin—thyroid cancer	0.00162	0.00227	CcSEcCtD
Histamine Phosphate—Pruritus—Sorafenib—thyroid cancer	0.00161	0.00224	CcSEcCtD
Histamine Phosphate—HRH1—trachea—thyroid cancer	0.00161	0.0286	CbGeAlD
Histamine Phosphate—Blood creatinine increased—Epirubicin—thyroid cancer	0.0016	0.00223	CcSEcCtD
Histamine Phosphate—Dehydration—Epirubicin—thyroid cancer	0.00159	0.00222	CcSEcCtD
Histamine Phosphate—Pain in extremity—Doxorubicin—thyroid cancer	0.00158	0.00221	CcSEcCtD
Histamine Phosphate—Dry skin—Epirubicin—thyroid cancer	0.00156	0.00218	CcSEcCtD
Histamine Phosphate—Abdominal pain upper—Epirubicin—thyroid cancer	0.00156	0.00218	CcSEcCtD
Histamine Phosphate—Diarrhoea—Sorafenib—thyroid cancer	0.00155	0.00217	CcSEcCtD
Histamine Phosphate—Gastritis—Epirubicin—thyroid cancer	0.00151	0.00211	CcSEcCtD
Histamine Phosphate—Muscular weakness—Epirubicin—thyroid cancer	0.0015	0.0021	CcSEcCtD
Histamine Phosphate—Cardiac arrest—Doxorubicin—thyroid cancer	0.0015	0.0021	CcSEcCtD
Histamine Phosphate—Dizziness—Sorafenib—thyroid cancer	0.0015	0.0021	CcSEcCtD
Histamine Phosphate—SLC22A5—thyroid gland—thyroid cancer	0.0015	0.0267	CbGeAlD
Histamine Phosphate—Abdominal distension—Epirubicin—thyroid cancer	0.00148	0.00207	CcSEcCtD
Histamine Phosphate—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00148	0.00207	CcSEcCtD
Histamine Phosphate—Asthma—Epirubicin—thyroid cancer	0.00147	0.00206	CcSEcCtD
Histamine Phosphate—Dysphagia—Epirubicin—thyroid cancer	0.00147	0.00206	CcSEcCtD
Histamine Phosphate—Dehydration—Doxorubicin—thyroid cancer	0.00147	0.00205	CcSEcCtD
Histamine Phosphate—Eosinophilia—Epirubicin—thyroid cancer	0.00146	0.00204	CcSEcCtD
Histamine Phosphate—Dry skin—Doxorubicin—thyroid cancer	0.00145	0.00202	CcSEcCtD
Histamine Phosphate—Vomiting—Sorafenib—thyroid cancer	0.00144	0.00202	CcSEcCtD
Histamine Phosphate—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00144	0.00201	CcSEcCtD
Histamine Phosphate—Rash—Sorafenib—thyroid cancer	0.00143	0.002	CcSEcCtD
Histamine Phosphate—Dermatitis—Sorafenib—thyroid cancer	0.00143	0.002	CcSEcCtD
Histamine Phosphate—Headache—Sorafenib—thyroid cancer	0.00142	0.00199	CcSEcCtD
Histamine Phosphate—Gastritis—Doxorubicin—thyroid cancer	0.0014	0.00195	CcSEcCtD
Histamine Phosphate—Muscular weakness—Doxorubicin—thyroid cancer	0.00139	0.00194	CcSEcCtD
Histamine Phosphate—Neutropenia—Epirubicin—thyroid cancer	0.00138	0.00193	CcSEcCtD
Histamine Phosphate—Abdominal distension—Doxorubicin—thyroid cancer	0.00137	0.00192	CcSEcCtD
Histamine Phosphate—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00137	0.00191	CcSEcCtD
Histamine Phosphate—Asthma—Doxorubicin—thyroid cancer	0.00136	0.00191	CcSEcCtD
Histamine Phosphate—Dysphagia—Doxorubicin—thyroid cancer	0.00136	0.00191	CcSEcCtD
Histamine Phosphate—Eosinophilia—Doxorubicin—thyroid cancer	0.00135	0.00189	CcSEcCtD
Histamine Phosphate—Nausea—Sorafenib—thyroid cancer	0.00135	0.00188	CcSEcCtD
Histamine Phosphate—Weight increased—Epirubicin—thyroid cancer	0.00134	0.00187	CcSEcCtD
Histamine Phosphate—Weight decreased—Epirubicin—thyroid cancer	0.00133	0.00186	CcSEcCtD
Histamine Phosphate—Pneumonia—Epirubicin—thyroid cancer	0.00132	0.00185	CcSEcCtD
Histamine Phosphate—Infestation—Epirubicin—thyroid cancer	0.00131	0.00184	CcSEcCtD
Histamine Phosphate—Infestation NOS—Epirubicin—thyroid cancer	0.00131	0.00184	CcSEcCtD
Histamine Phosphate—Renal failure—Epirubicin—thyroid cancer	0.00129	0.00181	CcSEcCtD
Histamine Phosphate—Stomatitis—Epirubicin—thyroid cancer	0.00128	0.00179	CcSEcCtD
Histamine Phosphate—SLC22A3—lymph node—thyroid cancer	0.00128	0.0228	CbGeAlD
Histamine Phosphate—Neutropenia—Doxorubicin—thyroid cancer	0.00128	0.00178	CcSEcCtD
Histamine Phosphate—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00127	0.00177	CcSEcCtD
Histamine Phosphate—Weight increased—Doxorubicin—thyroid cancer	0.00124	0.00173	CcSEcCtD
Histamine Phosphate—Weight decreased—Doxorubicin—thyroid cancer	0.00123	0.00172	CcSEcCtD
Histamine Phosphate—Pneumonia—Doxorubicin—thyroid cancer	0.00122	0.00171	CcSEcCtD
Histamine Phosphate—Infestation NOS—Doxorubicin—thyroid cancer	0.00122	0.0017	CcSEcCtD
Histamine Phosphate—Infestation—Doxorubicin—thyroid cancer	0.00122	0.0017	CcSEcCtD
Histamine Phosphate—Renal failure—Doxorubicin—thyroid cancer	0.0012	0.00167	CcSEcCtD
Histamine Phosphate—Stomatitis—Doxorubicin—thyroid cancer	0.00119	0.00166	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Epirubicin—thyroid cancer	0.00117	0.00164	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Epirubicin—thyroid cancer	0.00116	0.00162	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Epirubicin—thyroid cancer	0.00116	0.00162	CcSEcCtD
Histamine Phosphate—CA4—lymph node—thyroid cancer	0.00114	0.0203	CbGeAlD
Histamine Phosphate—HRH1—head—thyroid cancer	0.00113	0.0201	CbGeAlD
Histamine Phosphate—Flushing—Epirubicin—thyroid cancer	0.0011	0.00153	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Epirubicin—thyroid cancer	0.0011	0.00153	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00109	0.00152	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Doxorubicin—thyroid cancer	0.00108	0.0015	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00107	0.0015	CcSEcCtD
Histamine Phosphate—Angiopathy—Epirubicin—thyroid cancer	0.00107	0.0015	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Epirubicin—thyroid cancer	0.00106	0.00149	CcSEcCtD
Histamine Phosphate—Chills—Epirubicin—thyroid cancer	0.00106	0.00148	CcSEcCtD
Histamine Phosphate—Arrhythmia—Epirubicin—thyroid cancer	0.00105	0.00147	CcSEcCtD
Histamine Phosphate—Mental disorder—Epirubicin—thyroid cancer	0.00103	0.00144	CcSEcCtD
Histamine Phosphate—Erythema—Epirubicin—thyroid cancer	0.00103	0.00144	CcSEcCtD
Histamine Phosphate—Malnutrition—Epirubicin—thyroid cancer	0.00103	0.00144	CcSEcCtD
Histamine Phosphate—Flushing—Doxorubicin—thyroid cancer	0.00101	0.00142	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Doxorubicin—thyroid cancer	0.00101	0.00142	CcSEcCtD
Histamine Phosphate—Flatulence—Epirubicin—thyroid cancer	0.00101	0.00141	CcSEcCtD
Histamine Phosphate—Dysgeusia—Epirubicin—thyroid cancer	0.00101	0.00141	CcSEcCtD
Histamine Phosphate—Back pain—Epirubicin—thyroid cancer	0.000994	0.00139	CcSEcCtD
Histamine Phosphate—Angiopathy—Doxorubicin—thyroid cancer	0.000991	0.00138	CcSEcCtD
Histamine Phosphate—Muscle spasms—Epirubicin—thyroid cancer	0.000988	0.00138	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000984	0.00137	CcSEcCtD
Histamine Phosphate—Chills—Doxorubicin—thyroid cancer	0.00098	0.00137	CcSEcCtD
Histamine Phosphate—Arrhythmia—Doxorubicin—thyroid cancer	0.000976	0.00136	CcSEcCtD
Histamine Phosphate—Mental disorder—Doxorubicin—thyroid cancer	0.000957	0.00134	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Epirubicin—thyroid cancer	0.000953	0.00133	CcSEcCtD
Histamine Phosphate—Malnutrition—Doxorubicin—thyroid cancer	0.000951	0.00133	CcSEcCtD
Histamine Phosphate—Erythema—Doxorubicin—thyroid cancer	0.000951	0.00133	CcSEcCtD
Histamine Phosphate—Anaemia—Epirubicin—thyroid cancer	0.00095	0.00133	CcSEcCtD
Histamine Phosphate—Flatulence—Doxorubicin—thyroid cancer	0.000937	0.00131	CcSEcCtD
Histamine Phosphate—Dysgeusia—Doxorubicin—thyroid cancer	0.000931	0.0013	CcSEcCtD
Histamine Phosphate—SLC22A5—lymph node—thyroid cancer	0.00093	0.0166	CbGeAlD
Histamine Phosphate—Malaise—Epirubicin—thyroid cancer	0.000926	0.00129	CcSEcCtD
Histamine Phosphate—Vertigo—Epirubicin—thyroid cancer	0.000923	0.00129	CcSEcCtD
Histamine Phosphate—Leukopenia—Epirubicin—thyroid cancer	0.00092	0.00128	CcSEcCtD
Histamine Phosphate—Back pain—Doxorubicin—thyroid cancer	0.00092	0.00128	CcSEcCtD
Histamine Phosphate—Muscle spasms—Doxorubicin—thyroid cancer	0.000914	0.00128	CcSEcCtD
Histamine Phosphate—Palpitations—Epirubicin—thyroid cancer	0.000908	0.00127	CcSEcCtD
Histamine Phosphate—Cough—Epirubicin—thyroid cancer	0.000897	0.00125	CcSEcCtD
Histamine Phosphate—Convulsion—Epirubicin—thyroid cancer	0.00089	0.00124	CcSEcCtD
Histamine Phosphate—Hypertension—Epirubicin—thyroid cancer	0.000887	0.00124	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000882	0.00123	CcSEcCtD
Histamine Phosphate—Anaemia—Doxorubicin—thyroid cancer	0.000879	0.00123	CcSEcCtD
Histamine Phosphate—Myalgia—Epirubicin—thyroid cancer	0.000875	0.00122	CcSEcCtD
Histamine Phosphate—Arthralgia—Epirubicin—thyroid cancer	0.000875	0.00122	CcSEcCtD
Histamine Phosphate—Chest pain—Epirubicin—thyroid cancer	0.000875	0.00122	CcSEcCtD
Histamine Phosphate—Anxiety—Epirubicin—thyroid cancer	0.000872	0.00122	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000869	0.00121	CcSEcCtD
Histamine Phosphate—Discomfort—Epirubicin—thyroid cancer	0.000864	0.00121	CcSEcCtD
Histamine Phosphate—Malaise—Doxorubicin—thyroid cancer	0.000857	0.0012	CcSEcCtD
Histamine Phosphate—CYP2D6—head—thyroid cancer	0.000857	0.0153	CbGeAlD
Histamine Phosphate—Dry mouth—Epirubicin—thyroid cancer	0.000855	0.00119	CcSEcCtD
Histamine Phosphate—Vertigo—Doxorubicin—thyroid cancer	0.000854	0.00119	CcSEcCtD
Histamine Phosphate—Leukopenia—Doxorubicin—thyroid cancer	0.000851	0.00119	CcSEcCtD
Histamine Phosphate—Confusional state—Epirubicin—thyroid cancer	0.000845	0.00118	CcSEcCtD
Histamine Phosphate—Palpitations—Doxorubicin—thyroid cancer	0.00084	0.00117	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Epirubicin—thyroid cancer	0.000838	0.00117	CcSEcCtD
Histamine Phosphate—Infection—Epirubicin—thyroid cancer	0.000833	0.00116	CcSEcCtD
Histamine Phosphate—Cough—Doxorubicin—thyroid cancer	0.00083	0.00116	CcSEcCtD
Histamine Phosphate—Shock—Epirubicin—thyroid cancer	0.000825	0.00115	CcSEcCtD
Histamine Phosphate—Convulsion—Doxorubicin—thyroid cancer	0.000824	0.00115	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Epirubicin—thyroid cancer	0.000822	0.00115	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Epirubicin—thyroid cancer	0.000821	0.00115	CcSEcCtD
Histamine Phosphate—Hypertension—Doxorubicin—thyroid cancer	0.000821	0.00115	CcSEcCtD
Histamine Phosphate—Tachycardia—Epirubicin—thyroid cancer	0.000818	0.00114	CcSEcCtD
Histamine Phosphate—Skin disorder—Epirubicin—thyroid cancer	0.000814	0.00114	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Epirubicin—thyroid cancer	0.000811	0.00113	CcSEcCtD
Histamine Phosphate—Arthralgia—Doxorubicin—thyroid cancer	0.000809	0.00113	CcSEcCtD
Histamine Phosphate—Chest pain—Doxorubicin—thyroid cancer	0.000809	0.00113	CcSEcCtD
Histamine Phosphate—Myalgia—Doxorubicin—thyroid cancer	0.000809	0.00113	CcSEcCtD
Histamine Phosphate—Anxiety—Doxorubicin—thyroid cancer	0.000807	0.00113	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000804	0.00112	CcSEcCtD
Histamine Phosphate—Discomfort—Doxorubicin—thyroid cancer	0.0008	0.00112	CcSEcCtD
Histamine Phosphate—Anorexia—Epirubicin—thyroid cancer	0.000799	0.00112	CcSEcCtD
Histamine Phosphate—Dry mouth—Doxorubicin—thyroid cancer	0.000791	0.00111	CcSEcCtD
Histamine Phosphate—HRH1—lymph node—thyroid cancer	0.000789	0.0141	CbGeAlD
Histamine Phosphate—Hypotension—Epirubicin—thyroid cancer	0.000783	0.00109	CcSEcCtD
Histamine Phosphate—Confusional state—Doxorubicin—thyroid cancer	0.000782	0.00109	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000776	0.00108	CcSEcCtD
Histamine Phosphate—Infection—Doxorubicin—thyroid cancer	0.000771	0.00108	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000764	0.00107	CcSEcCtD
Histamine Phosphate—Shock—Doxorubicin—thyroid cancer	0.000763	0.00107	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Doxorubicin—thyroid cancer	0.000761	0.00106	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00076	0.00106	CcSEcCtD
Histamine Phosphate—Insomnia—Epirubicin—thyroid cancer	0.000758	0.00106	CcSEcCtD
Histamine Phosphate—Tachycardia—Doxorubicin—thyroid cancer	0.000757	0.00106	CcSEcCtD
Histamine Phosphate—Skin disorder—Doxorubicin—thyroid cancer	0.000754	0.00105	CcSEcCtD
Histamine Phosphate—Paraesthesia—Epirubicin—thyroid cancer	0.000753	0.00105	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00075	0.00105	CcSEcCtD
Histamine Phosphate—Dyspnoea—Epirubicin—thyroid cancer	0.000748	0.00104	CcSEcCtD
Histamine Phosphate—Anorexia—Doxorubicin—thyroid cancer	0.00074	0.00103	CcSEcCtD
Histamine Phosphate—Dyspepsia—Epirubicin—thyroid cancer	0.000738	0.00103	CcSEcCtD
Histamine Phosphate—Decreased appetite—Epirubicin—thyroid cancer	0.000729	0.00102	CcSEcCtD
Histamine Phosphate—Hypotension—Doxorubicin—thyroid cancer	0.000725	0.00101	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000724	0.00101	CcSEcCtD
Histamine Phosphate—Fatigue—Epirubicin—thyroid cancer	0.000723	0.00101	CcSEcCtD
Histamine Phosphate—Pain—Epirubicin—thyroid cancer	0.000717	0.001	CcSEcCtD
Histamine Phosphate—Constipation—Epirubicin—thyroid cancer	0.000717	0.001	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000707	0.000987	CcSEcCtD
Histamine Phosphate—Insomnia—Doxorubicin—thyroid cancer	0.000702	0.00098	CcSEcCtD
Histamine Phosphate—Paraesthesia—Doxorubicin—thyroid cancer	0.000697	0.000973	CcSEcCtD
Histamine Phosphate—Dyspnoea—Doxorubicin—thyroid cancer	0.000692	0.000966	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Epirubicin—thyroid cancer	0.000691	0.000965	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000686	0.000958	CcSEcCtD
Histamine Phosphate—Dyspepsia—Doxorubicin—thyroid cancer	0.000683	0.000954	CcSEcCtD
Histamine Phosphate—Decreased appetite—Doxorubicin—thyroid cancer	0.000674	0.000942	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00067	0.000936	CcSEcCtD
Histamine Phosphate—Fatigue—Doxorubicin—thyroid cancer	0.000669	0.000934	CcSEcCtD
Histamine Phosphate—Urticaria—Epirubicin—thyroid cancer	0.000666	0.000931	CcSEcCtD
Histamine Phosphate—Pain—Doxorubicin—thyroid cancer	0.000663	0.000927	CcSEcCtD
Histamine Phosphate—Constipation—Doxorubicin—thyroid cancer	0.000663	0.000927	CcSEcCtD
Histamine Phosphate—Body temperature increased—Epirubicin—thyroid cancer	0.000663	0.000926	CcSEcCtD
Histamine Phosphate—Abdominal pain—Epirubicin—thyroid cancer	0.000663	0.000926	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Doxorubicin—thyroid cancer	0.000639	0.000893	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000634	0.000886	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Epirubicin—thyroid cancer	0.000618	0.000863	CcSEcCtD
Histamine Phosphate—Urticaria—Doxorubicin—thyroid cancer	0.000616	0.000861	CcSEcCtD
Histamine Phosphate—Abdominal pain—Doxorubicin—thyroid cancer	0.000613	0.000857	CcSEcCtD
Histamine Phosphate—Body temperature increased—Doxorubicin—thyroid cancer	0.000613	0.000857	CcSEcCtD
Histamine Phosphate—Asthenia—Epirubicin—thyroid cancer	0.000602	0.00084	CcSEcCtD
Histamine Phosphate—Pruritus—Epirubicin—thyroid cancer	0.000593	0.000829	CcSEcCtD
Histamine Phosphate—Diarrhoea—Epirubicin—thyroid cancer	0.000574	0.000801	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Doxorubicin—thyroid cancer	0.000572	0.000798	CcSEcCtD
Histamine Phosphate—Asthenia—Doxorubicin—thyroid cancer	0.000557	0.000778	CcSEcCtD
Histamine Phosphate—Dizziness—Epirubicin—thyroid cancer	0.000554	0.000775	CcSEcCtD
Histamine Phosphate—Pruritus—Doxorubicin—thyroid cancer	0.000549	0.000767	CcSEcCtD
Histamine Phosphate—Vomiting—Epirubicin—thyroid cancer	0.000533	0.000745	CcSEcCtD
Histamine Phosphate—Diarrhoea—Doxorubicin—thyroid cancer	0.000531	0.000742	CcSEcCtD
Histamine Phosphate—Rash—Epirubicin—thyroid cancer	0.000529	0.000739	CcSEcCtD
Histamine Phosphate—Dermatitis—Epirubicin—thyroid cancer	0.000528	0.000738	CcSEcCtD
Histamine Phosphate—Headache—Epirubicin—thyroid cancer	0.000525	0.000734	CcSEcCtD
Histamine Phosphate—Dizziness—Doxorubicin—thyroid cancer	0.000513	0.000717	CcSEcCtD
Histamine Phosphate—Nausea—Epirubicin—thyroid cancer	0.000498	0.000696	CcSEcCtD
Histamine Phosphate—Vomiting—Doxorubicin—thyroid cancer	0.000493	0.000689	CcSEcCtD
Histamine Phosphate—Rash—Doxorubicin—thyroid cancer	0.000489	0.000683	CcSEcCtD
Histamine Phosphate—Dermatitis—Doxorubicin—thyroid cancer	0.000489	0.000683	CcSEcCtD
Histamine Phosphate—Headache—Doxorubicin—thyroid cancer	0.000486	0.000679	CcSEcCtD
Histamine Phosphate—Nausea—Doxorubicin—thyroid cancer	0.000461	0.000644	CcSEcCtD
Histamine Phosphate—HRH2—Signaling Pathways—TRIM33—thyroid cancer	0.000169	0.00329	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—TCF7L1—thyroid cancer	0.000167	0.00326	CbGpPWpGaD
Histamine Phosphate—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000163	0.00319	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—CALCB—thyroid cancer	0.000162	0.00317	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—SST—thyroid cancer	0.000161	0.00314	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00016	0.00312	CbGpPWpGaD
Histamine Phosphate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CDK1—thyroid cancer	0.00016	0.00312	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000159	0.00311	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—CALCA—thyroid cancer	0.000155	0.00302	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—HPGD—thyroid cancer	0.000154	0.00302	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—SST—thyroid cancer	0.000154	0.00301	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—TSHR—thyroid cancer	0.000154	0.003	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—PTCH1—thyroid cancer	0.000153	0.00299	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—MINPP1—thyroid cancer	0.00015	0.00294	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—CALCA—thyroid cancer	0.000148	0.0029	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CALCB—thyroid cancer	0.000147	0.00288	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—TCF7L1—thyroid cancer	0.000145	0.00284	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000142	0.00277	CbGpPWpGaD
Histamine Phosphate—SLC22A5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000141	0.00276	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—MINPP1—thyroid cancer	0.00014	0.00274	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—CDK1—thyroid cancer	0.00014	0.00273	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—SST—thyroid cancer	0.00014	0.00273	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—TSHR—thyroid cancer	0.000139	0.00272	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000139	0.00272	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—TPR—thyroid cancer	0.000138	0.00269	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000137	0.00268	CbGpPWpGaD
Histamine Phosphate—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000136	0.00265	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—PRKAR1A—thyroid cancer	0.000135	0.00265	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—CALCA—thyroid cancer	0.000135	0.00263	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—TSHR—thyroid cancer	0.000133	0.0026	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00013	0.00253	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—NDUFA13—thyroid cancer	0.000128	0.0025	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—TSHR—thyroid cancer	0.000122	0.00238	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—CDK1—thyroid cancer	0.000122	0.00238	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—CHST14—thyroid cancer	0.00012	0.00235	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—PRKAR1A—thyroid cancer	0.00012	0.00235	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—SST—thyroid cancer	0.000119	0.00233	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—NDUFA13—thyroid cancer	0.000119	0.00233	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000119	0.00233	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000119	0.00232	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000119	0.00232	CbGpPWpGaD
Histamine Phosphate—SLC22A5—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000119	0.00232	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—PTCH1—thyroid cancer	0.000119	0.00232	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000117	0.00228	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—CALCA—thyroid cancer	0.000115	0.00225	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—MEN1—thyroid cancer	0.000115	0.00224	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—PTCH1—thyroid cancer	0.000113	0.00221	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—TCF7L1—thyroid cancer	0.000113	0.0022	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—CHST14—thyroid cancer	0.000112	0.00219	CbGpPWpGaD
Histamine Phosphate—HRH1—IL-4 Signaling Pathway—AKT1—thyroid cancer	0.000112	0.00218	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000112	0.00218	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000111	0.00217	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000111	0.00216	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000111	0.00216	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000109	0.00213	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—SST—thyroid cancer	0.000108	0.00212	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—TSHR—thyroid cancer	0.000106	0.00208	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Biological oxidations—RXRA—thyroid cancer	0.000105	0.00206	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—PRKAR1A—thyroid cancer	0.000105	0.00204	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.000104	0.00204	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CALCA—thyroid cancer	0.000104	0.00204	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000104	0.00203	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—PTCH1—thyroid cancer	0.000104	0.00203	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—SST—thyroid cancer	0.000103	0.00202	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—SLC5A5—thyroid cancer	0.000103	0.00201	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—MEN1—thyroid cancer	9.99e-05	0.00195	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR ligand binding—CALCA—thyroid cancer	9.96e-05	0.00194	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—HPGD—thyroid cancer	9.69e-05	0.00189	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—SST—thyroid cancer	9.49e-05	0.00185	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—CDK1—thyroid cancer	9.45e-05	0.00185	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CALCA—thyroid cancer	9.14e-05	0.00178	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—PTCH1—thyroid cancer	9.04e-05	0.00176	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—HPGD—thyroid cancer	9.03e-05	0.00176	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.89e-05	0.00174	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—TPR—thyroid cancer	8.87e-05	0.00173	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—PRKAR1A—thyroid cancer	8.73e-05	0.0017	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CALCB—thyroid cancer	8.71e-05	0.0017	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—RXRA—thyroid cancer	8.66e-05	0.00169	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Neuronal System—BRAF—thyroid cancer	8.55e-05	0.00167	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.29e-05	0.00162	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CDK1—thyroid cancer	8.27e-05	0.00162	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—SST—thyroid cancer	8.26e-05	0.00161	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TRIM33—thyroid cancer	8.26e-05	0.00161	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—TSHR—thyroid cancer	8.24e-05	0.00161	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—PRKAR1A—thyroid cancer	8.11e-05	0.00158	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Neuronal System—BRAF—thyroid cancer	7.97e-05	0.00156	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CALCA—thyroid cancer	7.95e-05	0.00155	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—MEN1—thyroid cancer	7.75e-05	0.00151	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—MINPP1—thyroid cancer	7.74e-05	0.00151	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—MINPP1—thyroid cancer	7.67e-05	0.0015	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—TSHR—thyroid cancer	7.52e-05	0.00147	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.47e-05	0.00146	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CDK1—thyroid cancer	7.2e-05	0.00141	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—PTCH1—thyroid cancer	7.01e-05	0.00137	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.97e-05	0.00136	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.89e-05	0.00135	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—TSHR—thyroid cancer	6.83e-05	0.00133	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—PRKAR1A—thyroid cancer	6.72e-05	0.00131	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—SLC5A5—thyroid cancer	6.64e-05	0.0013	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—NRG1—thyroid cancer	6.64e-05	0.0013	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—NDUFA13—thyroid cancer	6.58e-05	0.00129	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—NDUFA13—thyroid cancer	6.53e-05	0.00127	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—SST—thyroid cancer	6.41e-05	0.00125	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—CHST14—thyroid cancer	6.19e-05	0.00121	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CALCA—thyroid cancer	6.17e-05	0.0012	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—CHST14—thyroid cancer	6.13e-05	0.0012	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—TERT—thyroid cancer	5.96e-05	0.00116	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—SST—thyroid cancer	5.85e-05	0.00114	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—PTCH1—thyroid cancer	5.8e-05	0.00113	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—NRG1—thyroid cancer	5.78e-05	0.00113	CbGpPWpGaD
Histamine Phosphate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	5.73e-05	0.00112	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—HIF1A—thyroid cancer	5.7e-05	0.00111	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—CALCA—thyroid cancer	5.63e-05	0.0011	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CDK1—thyroid cancer	5.58e-05	0.00109	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—RXRA—thyroid cancer	5.58e-05	0.00109	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—TPR—thyroid cancer	5.57e-05	0.00109	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TCF7L1—thyroid cancer	5.51e-05	0.00108	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	5.48e-05	0.00107	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—PPARG—thyroid cancer	5.47e-05	0.00107	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—SST—thyroid cancer	5.31e-05	0.00104	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—TERT—thyroid cancer	5.19e-05	0.00101	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—TPR—thyroid cancer	5.19e-05	0.00101	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.13e-05	0.001	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CALCA—thyroid cancer	5.11e-05	0.000998	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	5.1e-05	0.000997	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—MINPP1—thyroid cancer	5.06e-05	0.000988	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—NRAS—thyroid cancer	5.02e-05	0.000981	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—HPGD—thyroid cancer	4.99e-05	0.000974	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—HIF1A—thyroid cancer	4.96e-05	0.000969	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—HPGD—thyroid cancer	4.95e-05	0.000966	CbGpPWpGaD
Histamine Phosphate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	4.93e-05	0.000964	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	4.78e-05	0.000934	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—BRAF—thyroid cancer	4.72e-05	0.000922	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CDK1—thyroid cancer	4.63e-05	0.000903	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—NRG1—thyroid cancer	4.48e-05	0.000875	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—NRAS—thyroid cancer	4.37e-05	0.000854	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—KRAS—thyroid cancer	4.32e-05	0.000844	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.3e-05	0.00084	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—PTGS2—thyroid cancer	4.3e-05	0.00084	CbGpPWpGaD
Histamine Phosphate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	4.19e-05	0.000819	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—SLC5A5—thyroid cancer	4.17e-05	0.000814	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—BRAF—thyroid cancer	4.11e-05	0.000803	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—CHST14—thyroid cancer	4.05e-05	0.00079	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TSHR—thyroid cancer	4.03e-05	0.000788	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—TERT—thyroid cancer	4.02e-05	0.000786	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.01e-05	0.000783	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—PRKAR1A—thyroid cancer	3.97e-05	0.000775	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Neuronal System—HRAS—thyroid cancer	3.93e-05	0.000767	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—SLC5A5—thyroid cancer	3.88e-05	0.000758	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—HIF1A—thyroid cancer	3.85e-05	0.000752	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—MEN1—thyroid cancer	3.79e-05	0.00074	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—KRAS—thyroid cancer	3.76e-05	0.000735	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—PTEN—thyroid cancer	3.75e-05	0.000733	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—HRAS—thyroid cancer	3.67e-05	0.000718	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Neuronal System—HRAS—thyroid cancer	3.66e-05	0.000715	CbGpPWpGaD
Histamine Phosphate—HRH3—GPCR downstream signaling—AKT1—thyroid cancer	3.57e-05	0.000698	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—PPARG—thyroid cancer	3.52e-05	0.000688	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—RXRA—thyroid cancer	3.5e-05	0.000684	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—CCND1—thyroid cancer	3.45e-05	0.000673	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—PTCH1—thyroid cancer	3.43e-05	0.00067	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—NRAS—thyroid cancer	3.39e-05	0.000662	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—PTEN—thyroid cancer	3.33e-05	0.000649	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—RXRA—thyroid cancer	3.26e-05	0.000637	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—HPGD—thyroid cancer	3.26e-05	0.000637	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling by GPCR—AKT1—thyroid cancer	3.24e-05	0.000634	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—HRAS—thyroid cancer	3.2e-05	0.000625	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—BRAF—thyroid cancer	3.19e-05	0.000622	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—SST—thyroid cancer	3.14e-05	0.000612	CbGpPWpGaD
Histamine Phosphate—HRH4—GPCR downstream signaling—AKT1—thyroid cancer	3.11e-05	0.000607	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CALCA—thyroid cancer	3.02e-05	0.00059	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—CCND1—thyroid cancer	3e-05	0.000586	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—NRAS—thyroid cancer	2.97e-05	0.000579	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—KRAS—thyroid cancer	2.92e-05	0.00057	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—PTEN—thyroid cancer	2.89e-05	0.000565	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—TPR—thyroid cancer	2.87e-05	0.00056	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—TPR—thyroid cancer	2.84e-05	0.000555	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling by GPCR—AKT1—thyroid cancer	2.82e-05	0.000552	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.82e-05	0.00055	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2.79e-05	0.000546	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—PTGS2—thyroid cancer	2.77e-05	0.000541	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CDK1—thyroid cancer	2.73e-05	0.000534	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—NRAS—thyroid cancer	2.58e-05	0.000504	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—KRAS—thyroid cancer	2.55e-05	0.000499	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.53e-05	0.000495	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—HRAS—thyroid cancer	2.48e-05	0.000484	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—PTEN—thyroid cancer	2.42e-05	0.000472	CbGpPWpGaD
Histamine Phosphate—HRH2—GPCR downstream signaling—AKT1—thyroid cancer	2.41e-05	0.000471	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—CCND1—thyroid cancer	2.33e-05	0.000454	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—TP53—thyroid cancer	2.27e-05	0.000443	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—PTEN—thyroid cancer	2.24e-05	0.000438	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—KRAS—thyroid cancer	2.22e-05	0.000434	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PPARG—thyroid cancer	2.21e-05	0.000432	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—NRG1—thyroid cancer	2.19e-05	0.000428	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—AKT1—thyroid cancer	2.19e-05	0.000428	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—HRAS—thyroid cancer	2.17e-05	0.000424	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—AKT1—thyroid cancer	2.16e-05	0.000422	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.14e-05	0.000419	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.13e-05	0.000415	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PPARG—thyroid cancer	2.06e-05	0.000402	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—NRAS—thyroid cancer	2e-05	0.000391	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.99e-05	0.000389	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—TP53—thyroid cancer	1.98e-05	0.000386	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TERT—thyroid cancer	1.97e-05	0.000385	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—AKT1—thyroid cancer	1.92e-05	0.000374	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—HRAS—thyroid cancer	1.89e-05	0.000369	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—HIF1A—thyroid cancer	1.88e-05	0.000368	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—TPR—thyroid cancer	1.87e-05	0.000366	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.84e-05	0.00036	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—RXRA—thyroid cancer	1.8e-05	0.000352	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—RXRA—thyroid cancer	1.79e-05	0.000349	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PTGS2—thyroid cancer	1.74e-05	0.00034	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.74e-05	0.000339	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—KRAS—thyroid cancer	1.72e-05	0.000337	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—AKT1—thyroid cancer	1.67e-05	0.000326	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.66e-05	0.000324	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PTGS2—thyroid cancer	1.62e-05	0.000316	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.56e-05	0.000305	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—TP53—thyroid cancer	1.53e-05	0.000299	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PTEN—thyroid cancer	1.52e-05	0.000296	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—HRAS—thyroid cancer	1.47e-05	0.000286	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.43e-05	0.000279	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PTEN—thyroid cancer	1.41e-05	0.000276	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.4e-05	0.000274	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—AKT1—thyroid cancer	1.39e-05	0.000272	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—AKT1—thyroid cancer	1.29e-05	0.000253	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—HRAS—thyroid cancer	1.21e-05	0.000237	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	1.18e-05	0.00023	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—RXRA—thyroid cancer	1.18e-05	0.00023	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CCND1—thyroid cancer	1.14e-05	0.000222	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PPARG—thyroid cancer	1.14e-05	0.000222	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PPARG—thyroid cancer	1.13e-05	0.00022	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—PTEN—thyroid cancer	1.1e-05	0.000215	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—AKT1—thyroid cancer	1.07e-05	0.000209	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—NRAS—thyroid cancer	9.8e-06	0.000191	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PTGS2—thyroid cancer	8.95e-06	0.000175	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PTGS2—thyroid cancer	8.87e-06	0.000173	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—AKT1—thyroid cancer	8.74e-06	0.000171	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—KRAS—thyroid cancer	8.44e-06	0.000165	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—AKT1—thyroid cancer	8.14e-06	0.000159	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PTEN—thyroid cancer	7.81e-06	0.000152	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PTEN—thyroid cancer	7.74e-06	0.000151	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TP53—thyroid cancer	7.5e-06	0.000146	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PPARG—thyroid cancer	7.44e-06	0.000145	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—HRAS—thyroid cancer	7.17e-06	0.00014	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—AKT1—thyroid cancer	6.33e-06	0.000124	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.85e-06	0.000114	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PTEN—thyroid cancer	5.1e-06	9.97e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—AKT1—thyroid cancer	4.5e-06	8.79e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—AKT1—thyroid cancer	4.46e-06	8.71e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—AKT1—thyroid cancer	2.94e-06	5.74e-05	CbGpPWpGaD
